Pasithea Therapeutics (KTTA) Current Leases (2022 - 2024)
Historic Current Leases for Pasithea Therapeutics (KTTA) over the last 3 years, with Q1 2024 value amounting to $32989.0.
- Pasithea Therapeutics' Current Leases fell 8000.35% to $32989.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $32989.0, marking a year-over-year decrease of 8000.35%. This contributed to the annual value of $81680.0 for FY2023, which is 4906.52% down from last year.
- Pasithea Therapeutics' Current Leases amounted to $32989.0 in Q1 2024, which was down 8000.35% from $81680.0 recorded in Q4 2023.
- Pasithea Therapeutics' 5-year Current Leases high stood at $258031.0 for Q3 2022, and its period low was $32989.0 during Q1 2024.
- In the last 3 years, Pasithea Therapeutics' Current Leases had a median value of $162668.0 in 2022 and averaged $142950.1.
- Its Current Leases has fluctuated over the past 5 years, first skyrocketed by 6730.36% in 2023, then plummeted by 8000.35% in 2024.
- Pasithea Therapeutics' Current Leases (Quarter) stood at $160362.0 in 2022, then crashed by 49.07% to $81680.0 in 2023, then crashed by 59.61% to $32989.0 in 2024.
- Its last three reported values are $32989.0 in Q1 2024, $81680.0 for Q4 2023, and $174471.0 during Q3 2023.